Literature DB >> 18400571

Biology of intestinal metaplasia in 2008: more than a simple phenotypic alteration.

L Gutiérrez-González1, N A Wright.   

Abstract

This review concentrates on one main aspect of cancerization in the oesophagus and stomach: principally, intestinal metaplasia. There are at least two other important pathways that lead to cancer and do not need such a morphological transformation. One is the gastric type of carcinoma on the Lauren classification, which arises directly from the stem cell zone and is the signet ring form of cancer, while the other is spasmolytic polypeptide-expressing metaplasia (SPEM)--spasmolytic polypeptide (TFF2) expressing metaplasia, where the gastric glands become filled with TFF2-expressing cells and may also lead to gastric dysplasia and cancer. The development of intestinal metaplasia is complex. Here, we examine intestinal metaplasia in molecular terms, noting the over-expression of Cdx1, Cdx2, Pdx1, Oct1, TFF3 and the downregulation of Hedgehog signalling; Runx3 is deactivated by epigenetic silencing, and pathways such as Wnt and MARK/ERK are involved. These changes start to explain the principles of the development of intestinal metaplasia and suggest that the regulation of these genes is of importance in the development of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18400571     DOI: 10.1016/j.dld.2008.02.029

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  22 in total

1.  Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment.

Authors:  Massimo Rugge; Matteo Fassan; Marco Pizzi; Fabio Farinati; Giacomo Carlo Sturniolo; Mario Plebani; David Y Graham
Journal:  World J Gastroenterol       Date:  2011-11-07       Impact factor: 5.742

Review 2.  Early events during neoplastic progression in Barrett's esophagus.

Authors:  Brian J Reid
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

Review 3.  Pathology of gastric intestinal metaplasia: clinical implications.

Authors:  Pelayo Correa; M Blanca Piazuelo; Keith T Wilson
Journal:  Am J Gastroenterol       Date:  2010-03       Impact factor: 10.864

4.  [Continual self-renewal of the gastric epithelium by cell differentiation: implications for carcinogenesis].

Authors:  W Hoffmann
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

5.  Impaired gastric gland differentiation in Peutz-Jeghers syndrome.

Authors:  Lina Udd; Pekka Katajisto; Marika Kyyrönen; Ari P Ristimäki; Tomi P Mäkelä
Journal:  Am J Pathol       Date:  2010-04-02       Impact factor: 4.307

6.  Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer.

Authors:  Hyuk-Joon Lee; Ki Taek Nam; Heae Surng Park; Min A Kim; Bonnie J Lafleur; Hiroyuki Aburatani; Han-Kwang Yang; Woo Ho Kim; James R Goldenring
Journal:  Gastroenterology       Date:  2010-04-13       Impact factor: 22.682

Review 7.  Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence.

Authors:  Veronique Giroux; Anil K Rustgi
Journal:  Nat Rev Cancer       Date:  2017-09-01       Impact factor: 60.716

8.  Gastric carcinogenesis.

Authors:  Ismail Gomceli; Baris Demiriz; Mesut Tez
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

9.  Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1.

Authors:  Carol W M Chan; Newton A Wong; Ying Liu; David Bicknell; Helen Turley; Laura Hollins; Crispin J Miller; Jennifer L Wilding; Walter F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-02       Impact factor: 11.205

10.  Intestinal metaplasia in liver of rats after partial hepatectomy and treatment with acetylaminofluorene.

Authors:  V Barut; C E Sarraf
Journal:  Cell Prolif       Date:  2009-07-17       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.